Mechanism of simvastatin-induced K562 cell apoptosis

Yong-Chang Yang1, Dai-Wen Xiao, Hua Liu

  • 1Clinical Laboratory Department, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China.

Pharmacology
|September 5, 2009
PubMed

Insights

Simvastatin, a statin, inhibits chronic myelogenous leukemia (CML) cell growth and induces apoptosis by increasing reactive oxygen species (ROS), calcium, and nitric oxide (NO) via inducible NO synthase (iNOS). These mechanisms clarify statin

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Statins are utilized in cancer therapy and prevention, but their molecular mechanisms remain unclear.
  • Chronic myelogenous leukemia (CML) is a significant target for statin-based therapies.

Purpose of the Study:

  • To investigate the effects of simvastatin on K562 cells, a CML cell line.
  • To elucidate the molecular mechanisms underlying simvastatin's anti-cancer effects, focusing on cell proliferation, apoptosis, and related molecules.

Main Methods:

  • K562 cells were treated with simvastatin.
  • Assays were performed to measure cell proliferation, apoptosis, reactive oxygen species (ROS), intracellular calcium concentration, and nitric oxide (NO) levels.
  • Inducible NO synthase (iNOS) mRNA expression was analyzed.

Main Results:

  • Simvastatin significantly reduced K562 cell proliferation and induced apoptosis.
  • Treatment with simvastatin led to increased levels of ROS and intracellular calcium.
  • Elevated nitric oxide (NO) content and increased iNOS mRNA expression were observed in simvastatin-treated cells.

Conclusions:

  • Simvastatin exhibits anti-proliferative and apoptotic effects on K562 cells.
  • Increased ROS, intracellular calcium, and NO production via iNOS contribute to simvastatin's observed effects.
  • These findings provide insights into the molecular mechanisms of statins in CML therapy.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...